Reference health
Leishmanicidal and Immunomodulatory Activities of the Palladacycle Complex DPPE 1.1, a Potential Candidate for Treatment of Cutaneous Leishmaniasis
50/50 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 50 checked references that resolve
resolves10.1016/j.cimid.2017.02.001
Wound healing in cutaneous leishmaniasis: A double edged sword of IL-10 and TGF-β
resolves10.1007/BF00918183
Detection of lymphocyte subsets using three-color/single-laser flow cytometry and the fluorescent dye Peridinin chlorophyll-a protein
resolves10.1111/j.0141-9838.2004.00691.x
Th1 and Th2 immunological profile induced by cysteine proteinase in murine leishmaniasis
resolves10.1016/0014-4894(90)90024-7
Lysosomal depletion in macrophages from spleen and foot lesions of Leishmania-infected hamster
resolves10.1016/j.ejphar.2006.06.004
Biphosphinic palladacycle complex mediates lysosomal-membrane permeabilization and cell death in K562 leukaemia cells
resolves10.1126/science.1636092
Transforming Growth Factor-β in Leishmanial Infection: a Parasite Escape Mechanism
resolves10.1016/S0166-6851(97)00072-8
Cathepsin B-like cysteine proteinase-deficient mutants of Leishmania mexicana
resolves10.1016/j.bmc.2005.01.057
Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents
resolves10.2174/187152007781668661
Recent Advances Involving Palladium (II) Complexes for the Cancer Therapy
resolves10.1128/IAI.72.4.2194-2202.2004
Identification and Molecular Characterization of a Gene Encoding a Protective<i>Leishmania amazonensis</i>Trp-Asp (WD) Protein
resolves10.1371/journal.pone.0013815
Neutrophils Reduce the Parasite Burden in Leishmania (Leishmania) amazonensis-Infected Macrophages
resolves10.1128/IAI.71.7.3988-3994.2003
Immune Responses Induced by the<i>Leishmania</i>(<i>Leishmania</i>)<i>donovani</i>A2 Antigen, but Not by the LACK Antigen, Are Protective against Experimental<i>Leishmania</i>(<i>Leishmania</i>)<i>amazonensis</i>Infection
resolves10.1128/IAI.71.6.3172-3182.2003
Perforin and Gamma Interferon Are Critical CD8<sup>+</sup>T-Cell-Mediated Responses in Vaccine-Induced Immunity against<i>Leishmania amazonensis</i>Infection
resolves10.1016/j.ab.2004.09.012
Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides to define substrate specificity of carboxydipeptidases: assays with human cathepsin B
resolves10.1016/j.pt.2003.09.008
Leishmaniasis– current chemotherapy and recent advances in the search for novel drugs
resolves10.1016/j.exppara.2009.09.003
Partial protective responses induced by a recombinant cysteine proteinase from Leishmania (Leishmania) amazonensis in a murine model of cutaneous leishmaniasis
resolves10.2174/092986708783503221
Anticancer Compounds as Leishmanicidal Drugs: Challenges in Chemotherapy and Future Perspectives
resolves10.1586/eri.10.19
Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis
resolves10.1128/AAC.00137-11
CpG Oligodeoxynucleotide 2006 and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis
resolves10.4269/ajtmh.2005.73.1005
A PHASE II DOSE-RANGING STUDY OF SITAMAQUINE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN INDIA
resolves10.1016/S0169-4758(96)40010-2
A simple method for quantifying Leishmania in tissues of infected animals
resolves10.1128/AAC.00323-10
<i>In Vitro</i>
and
<i>In Vivo</i>
Trypanocidal Effects of the Cyclopalladated Compound 7a, a Drug Candidate for Treatment of Chagas' Disease
resolves10.1016/S1369-5274(98)80065-9
Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions
resolves10.1073/pnas.93.12.6008
Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors.
resolves10.4269/ajtmh.2007.76.669
MACROPHAGE KILLING OF LEISHMANIA AMAZONENSIS AMASTIGOTES REQUIRES BOTH NITRIC OXIDE AND SUPEROXIDE
resolves10.3390/ijms11093158
Synthesis and Characterization of a Heteroleptic Ru(II) Complex of Phenanthroline Containing Oligo-Anthracenyl Carboxylic Acid Moieties
resolves10.1371/journal.pntd.0001626
In Vitro and In Vivo Activity of a Palladacycle Complex on Leishmania (Leishmania) amazonensis
resolves10.3389/fmicb.2017.00333
Treatment of Leishmania (Leishmania) Amazonensis-Infected Mice with a Combination of a Palladacycle Complex and Heat-Killed Propionibacterium acnes Triggers Protective Cellular Immune Responses
resolves10.1016/j.vetpar.2008.09.015
Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis
resolves10.1186/1471-2172-12-44
In silico predicted epitopes from the COOH-terminal extension of cysteine proteinase B inducing distinct immune responses during Leishmania (Leishmania) amazonensis experimental murine infection
resolves10.1016/j.micinf.2005.04.016
TGF-β-associated enhanced susceptibility to leishmaniasis following intramuscular vaccination of mice with Leishmania amazonensis antigens
resolves10.1128/IAI.72.8.4521-4527.2004
Intranasal Vaccination against Cutaneous Leishmaniasis with a Particulated Leishmanial Antigen or DNA Encoding LACK
resolves10.1128/IAI.72.2.988-995.2004
Enhanced Replication of<i>Leishmania amazonensis</i>Amastigotes in Gamma Interferon-Stimulated Murine Macrophages: Implications for the Pathogenesis of Cutaneous Leishmaniasis
resolves10.1002/ijc.11434
Cyclopalladated compounds as chemotherapeutic agents: Antitumor activity against a murine melanoma cell line
resolves10.1128/IAI.66.3.1233-1236.1998
Transforming Growth Factor β and Immunosuppression in Experimental Visceral Leishmaniasis
resolves10.1042/BJ20080972
Palladacycles catalyse the oxidation of critical thiols of the mitochondrial membrane proteins and lead to mitochondrial permeabilization and cytochrome <i>c</i> release associated with apoptosis
resolves10.1128/AAC.00273-15
Sequential Chemoimmunotherapy of Experimental Visceral Leishmaniasis Using a Single Low Dose of Liposomal Amphotericin B and a Novel DNA Vaccine Candidate
resolves10.1002/jmr.2334
Dynamic identification of H2 epitopes from <i>Leishmania (Leishmania) amazonensis</i> cysteine proteinase B with potential immune activity during murine infection
resolves10.1055/s-0030-1250663
Current Approaches to Discover Marine Antileishmanial Natural Products
resolves10.1016/S0035-9203(00)90130-5
A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis
resolves10.1128/AAC.00688-17
Efficacy of a Binuclear Cyclopalladated Compound Therapy for Cutaneous Leishmaniasis in the Murine Model of Infection with Leishmania amazonensis and Its Inhibitory Effect on Topoisomerase 1B
resolves10.5935/0103-5053.20150360
Antiprotozoal Activity of the Cyclopalladated Complexes Against<i>Leishmania amazonensis</i>and<i>Trypanosoma cruzi</i>
resolves10.1128/IAI.71.3.1225-1233.2003
Nitric Oxide Partially Controls<i>Coxiella burnetii</i>Phase II Infection in Mouse Primary Macrophages
The 5 references without a DOI — listed, not checked
no DOI — not checkedImmunopathology of experimental cutaneous leishmaniasis.
no DOI — not checked“Evolution, classification and geographical distribution,” in
no DOI — not checked“New World leishmaniasis - the neotropical Leishmania species,” in
no DOI — not checkedLeishmaniasis: drug resistance and natural products (review).
no DOI — not checkedB53
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.3389/fmicb.2018.01427"><img src="https://citestamp.com/citestamped/10.3389/fmicb.2018.01427/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.3389/fmicb.2018.01427)